1,242
Views
1
CrossRef citations to date
0
Altmetric
Editorial Comment

Impact of diabetes and metformin use on prostate cancer

&
Pages 508-509 | Received 27 Jul 2020, Accepted 01 Aug 2020, Published online: 13 Aug 2020

References

  • Hamilton RJ. Metformin for castrate-resistant prostate cancer: learning more about an old dog’s new tricks. Eur Urol. 2014;66(3):475–477.
  • Rothermundt C, Hayoz S, Templeton AJ, et al. Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). Eur Urol. 2014;66(3):468–474.
  • Gillessen S, Gilson C, James N, et al. Repurposing metformin as therapy for prostate cancer within the STAMPEDE Trial Platform. Eur Urol. 2016;70(6):906–908.
  • Fall K, Garmo H, Gudbjornsdottir S, et al. Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden. Cancer Epidemiol Biomarkers Prev. 2013;22:1102–1109.
  • Haring A, Murtola TJ, Talala K, et al. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. Scand J Urol. 2017;51(1):5–12.
  • Preston MA, Riis AH, Ehrenstein V, et al. Metformin use and prostate cancer risk. Eur Urol. 2014;66(6):1012–1020.
  • Patasius A, Innos K, Barchuk A, et al. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine. BMJ Open. 2019;9(10):e031856.
  • Kincius M, Patasius A, Linkeviciute-Ulinskiene D, et al. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients. Aging Male. 2020;1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.